Lido Advisors
BCAB

Lido Advisors’s BIOATLA INC BCAB Stock Holding History

Lido Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69K Buy
+16,656
New +$70.6K ﹤0.01% 2074

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Lido Advisors's BCAB Position: Q2 2026 in Review

Lido Advisors opened a new position in BIOATLA INC (BCAB) in Q2 2026: 16,656 shares worth $69K. The stake represents ﹤0.01% of the portfolio and ranks #2074 among its holdings.

21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Lido Advisors held 16,656 shares of BIOATLA INC worth $69K as of Q2 2026.
  • BIOATLA INC was a new Lido Advisors position in Q2 2026.
  • BIOATLA INC made up ﹤0.01% of Lido Advisors's portfolio in Q2 2026, its #2074 holding.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.